<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2017-4-6-21</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-1599</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Постреанимационные изменения экспрессии мозгового нейротрофического фактора (BDNF): взаимосвязь с процессом гибели нейронов</article-title><trans-title-group xml:lang="en"><trans-title>Postresuscitative Changes of Brain-Derived Neurotrophic Factor (BDNF) Protein Expression: Association With Neuronal Death</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аврущенко</surname><given-names>М. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Avrushchenko</surname><given-names>M. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>10703, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Build. 2, Moscow 107031</p></bio><email xlink:type="simple">maria_avr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Острова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostrova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>10703, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Build. 2, Moscow 107031</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ общей реаниматологии им. В. А. Неговского, ФНКЦ реаниматологии и реабилитологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>07</day><month>09</month><year>2017</year></pub-date><volume>13</volume><issue>4</issue><fpage>6</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аврущенко М.Ш., Острова И.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Аврущенко М.Ш., Острова И.В.</copyright-holder><copyright-holder xml:lang="en">Avrushchenko M.S., Ostrova I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/1599">https://www.reanimatology.com/rmt/article/view/1599</self-uri><abstract><sec><title>Цель</title><p>Цель: выявить взаимосвязь между уровнем экспрессии BDNF и развитием постреанимационной гибели нейронов в высокочувствительных к гипоксии отделах мозга.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. На разных сроках постреанимационного периода (1-, 4-, 7-, 14-е сутки) исследовали состояние высокочувствительных к гипоксии нейрональных популяций (пирамидные нейроны гиппокампа и клетки Пуркинье мозжечка) у белых половозрелых крыс-самцов, перенесших 10-минутную остановку системного кровообращения (пережатие сосудистого пучка сердца). Контролем служили ложнооперированные животные. Проводили иммуногистохимическое выявление BDNF-иммунореактивных нейронов с последующим определением оптической плотности, числа клеток с разным уровнем экспрессии BDNF и общего числа нейронов на 1 мм длины их слоя. Использовали системы анализа изображений (компьютер Intel, микроскоп Olympus BX-41, программы ImadgeScopeM, ImageJ 1,48v, Excel 2007). Статистическую обработку данных проводили в программе Statistica 7.0. с использованием критериев λ Колмогорова-Смирнова, U-критерия Манна-Уитни и t-критерия Стьюдента.</p></sec><sec><title>Результаты</title><p>Результаты. Установили динамику постреанимационных сдвигов BDNиммунореактивности нейрональных популяций пирамидных клеток гиппокампа и клеток Пуркинье мозжечка. Показали, что в обеих нейрональных популяциях происходит снижение уровня экспрессии BDNF, что сопровождается гибелью нейронов. Установили, что процесс выпадения (гибели) клеток Пуркинье мозжечка происходит к 4-м суткам после реанимации, а пирамидных нейронов гиппокампа — только к 7-м. Существенно, что в обеих нейрональных популяциях гибели подвергаются BDN-негативные и слабопозитивные нервные клетки.</p></sec><sec><title>Заключение</title><p>Заключение. Результаты проведенных исследований свидетельствуют о наличии взаимосвязи между сдвигами экспрессии BDNF и постреанимационной гибелью нейронов. Показано, что в высокочувствительных к гипоксии нейрональных популяциях гибели подвергаются только неэкспрессирующие и слабоэкспрессирующие BDNF клетки. Полученные результаты дают основание заключить, что уровень экспрессии BDNF в нейронах является одним из факторов, оказывающих существенное влияние на их устойчивость к ишемии-реперфузии. Обсуждается возможность активации уровня экспрессии эндогенного BDNF для предотвращения гибели нейронов. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim of the study</title><p>Aim of the study: to evaluate expression level of BDNF and its association with the postresuscitative neuronal death in highly hypoxia-sensitive brain regions.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Cardiac arrest in adult albino male rats was evoked by intrathoracic clamping of supracardiac bundle of vessels for 10 min. Pyramidal neurons of the hippocampus and Purkinje cells of the cerebellum were analyzed at various time points after resuscitation (days 1, 4, 7, 14). Shame-operated rats served as controls. The expression of BDNF protein was immunohistochemically determined. The BDNF expression level was determined by evalution on the base of the average optical density. The number of neurons with different BDNF expression levels and the total number of neurons per 1 mm of the layer length were computed. Image analysis systems (Intel personal computer, Olympus BX-41 microscope, ImageScopeM, ImageJ 1,48v and MS Excel 2007 software packages) were used in the study. Data statistical processing was performed with the aid of Statistica 7.0 program and Kolmogorov-Smirnov λ-test, Mann-Whitney U-test and Student's t-test.</p></sec><sec><title>Results</title><p>Results. The dynamics of postresuscitative shifts of BDNF immunoreactivity in neuronal populations of hippocampal pyramidal cells and cerebellar Purkinje cells was established. It was shown that the level of BDNF expression within the two neuronal populations decreased, that was accompanied by neuronal death. In the Purkinje cell population the neuronal death occurred by the 4th day after resuscitation, while in the hippocampus, it occurs only by the 7th day. Notably, only BDNF-negative neurons or neurons with low level of BDNF expression died in both neuronal populations.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results of the study indicate the existence of an interrelation between the shifts in BDNF expression and the postresuscitative neuronal death. It was shown that only the cells with none or poor BDNF expression underwent death in highly hypoxia-sensitive neuronal populations. The results suggest that the level of BDNF expression is one of factors that have a significant effect on neuronal resistance to ischemia-reperfusion. A possibility of induction of the endogenous BDNF expression in order to prevent neuronal death is discussed. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мозговой нейротрофический фактор (BDNF)</kwd><kwd>постреанимационный период</kwd><kwd>гибель нейронов</kwd><kwd>пирамидные клетки гиппокампа</kwd><kwd>клетки Пуркинье мозжечка</kwd><kwd>иммуногистохимия</kwd><kwd>оптическая плотность</kwd><kwd>морфометрический анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>brain derived neurotrophic factor (BDNF)</kwd><kwd>postresuscitative period</kwd><kwd>neuronal death</kwd><kwd>pyramidal cells of the hippocampus</kwd><kwd>Purkinje cells of the cerebellum</kwd><kwd>immunohistochemistry</kwd><kwd>mean optical density</kwd><kwd>morphometric analysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Т.Н.Васильева</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Мороз В.В., Острова И.В. Постреанимационные изменения мозга на уровне нейрональных популяций: закономерности и механизмы. Общая реаниматология. 2012; 8 (4): 69-78. DOI: 10.15360/1813-9779-2012-4-69</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Moroz V.V., Ostrova I.V. Postresuscitation changes in the brain at the level of neuronal populations: patterns and mecha- nisms. Obshchaya Reanimatologiya = General Reanimatology. 2012; 8 (4): 69-78. DOI: 10.15360/1813-9779-2012-4-69. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Острова И.В., Волков А.В., Заржецкий Ю.В. Постреанимационные изменения морфофункционального состояния нервных клеток: значение в патогенезе энцефалопатий. Общая реаниматология. 2006; 2 (5-6): 85-97. DOI: 10.15360/1813-9779-2006-6-85-96</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Ostrova I.V., Volkov A.V., Zarzhetsky Yu.V. Postresuscitative changes in the morphofunctional state of nerve cells: implication in the pathogenesis of encephalopathies. Obshchaya Reanimatologiya = General Reanimatology. 2006; 2 (5-6): 85-97. DOI: 10.15360/1813-9779-2006-6-85-96. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Острова И.В., Аврущенко М.Ш. Экспрессия мозгового нейротрофического фактора (BDNF) повышает устойчивость нейронов к гибели в постреанимационном периоде. Общая реаниматология. 2015; 11 (3): 45-53. DOI: 10.15360/1813-9779-2015-3-45-f53</mixed-citation><mixed-citation xml:lang="en">Ostrova I.V., Avrushchenko M.S. Expression of Brain-Derived Neurotrophic Factor (BDNF) increases the resistance of neurons to death in the postresuscitation period. Obshchaya Reanimatologiya = General Reanimatology. 2015; 11 (3): 45-53. DOI: 10.15360/1813- 9779-2015-3-45-53. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Острова И.В., Мороз В.В., Аврущенко М.Ш. Значение иммуногистохимических исследований белков теплового шока семейства HSP70 для изучения постреанимационных изменений мозга. Общая реаниматология. 2007; 3 (6): 91-96. DOI: 10.15360/1813-9779-2007-6-91-96</mixed-citation><mixed-citation xml:lang="en">Ostrova I.V., Moroz V.V., Avrushchenko M.Sh. Significance of immuno- histochemical studies of heat shock proteins of the HSP70 family in the investigation of postresuscitative brain changes. Obshchaya Reanimatologiya = General Reanimatology. 2007; 3 (5-6): 91-96. DOI: 10.15360/1813-9779-2007-6-91-96. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Острова И.В., Аврущенко М.Ш., Волков А.В. Взаимосвязь уровня экспрессии белка GRP78 с выраженностью постишемического повреждения гиппокампа у крыс разного пола. Общая реаниматология. 2011; 7 (6): 28-33. DOI: 10.15360/1813-9779-2011-6-28</mixed-citation><mixed-citation xml:lang="en">Ostrova I.V., Avrushchenko M.Sh., Volkov A.V. Association of GRP78 protein expression with the degree of postischemic hippocampal dam- age in rats of both sexes. Obshchaya Reanimatologiya = General Reanimatology. 2011; 7 (6): 28-33. DOI: 10.15360/1813-9779-2011-6- 28. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Острова И.В., Волков А.В. Постреанимационные изменения экспрессии глиального нейротрофического фактора (GDNF): взаимосвязь с повреждением клеток Пуркинье мозжечка (экспериментальное исследование). Общая реаниматология. 2014; 10 (5): 59-68. DOI: 10.15360/1813-9779-2014-5-59-68</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Ostrova I.V., Volkov A.V. Postresuscitation changes in the expression of GlialDerived Neurotrophic Factor (GDNF): associ- ation with cerebellar Purkinje cell damage (an experimental study). Obshchaya Reanimatologiya = General Reanimatology. 2014; 10 (5): 59- 68. DOI: 10.15360/1813-9779-2014-5-59-68. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Острова И.В. Значение основного фактора роста фибробластов (bFGF) в развитии постреанимационных изменений популяции клеток Пуркинье мозжечка. Общая реаниматология. 2016; 12 (1): 8-15. DOI: 10.15360/1813-9779-2016-1-8-15</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Ostrova I.V. Significance of Basic Fibroblast Growth Factor (BFGF) in the development of postresuscitation changes in population of cerebellar Purkinje cells. Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (1): 8-15. DOI: 10.15360/1813-9779-2016-1-8-15. [In Russ., In Engl.]</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Larpthaveesarp A., Ferriero D.M., Gonzalez F.F. Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci. 2015; 5 (2): 165-177. DOI: 10.3390/brainsci5020165. PMID: 25942688</mixed-citation><mixed-citation xml:lang="en">Larpthaveesarp A., Ferriero D.M., Gonzalez F.F. Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci. 2015; 5 (2): 165-177. DOI: 10.3390/brainsci5020165. PMID: 25942688</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura A., Namekata K., Guo X., Harada C., Harada T. Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int. J. Mol. Sci. 2016; 17 (9): pii: E1584. DOI: 10.3390/ijms17091584. PMID: 27657046</mixed-citation><mixed-citation xml:lang="en">Kimura A., Namekata K., Guo X., Harada C., Harada T. Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int. J. Mol. Sci. 2016; 17 (9): pii: E1584. DOI: 10.3390/ijms17091584. PMID: 27657046</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gray J.D., Milner T.A., McEwen B.S. Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience. 2013; 239: 214-227. DOI: 10.1016/j.neuroscience.2012.08.034. PMID: 22922121</mixed-citation><mixed-citation xml:lang="en">Gray J.D., Milner T.A., McEwen B.S. Dynamic plasticity: the role of glu- cocorticoids, brain-derived neurotrophic factor and other trophic fac- tors. Neuroscience. 2013; 239: 214-227. DOI: 10.1016/j.neuro- science.2012.08.034. PMID: 22922121</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hempstead B.L. Brain-derived neurotrophic factor: three ligands, many actions. Trans. Am. Clin. Climatol. Assoc. 2015; 126: 9-19. PMID: 26330656</mixed-citation><mixed-citation xml:lang="en">Hempstead B.L. Brain-derived neurotrophic factor: three ligands, many actions. Trans. Am. Clin. Climatol. Assoc. 2015; 126: 9-19. PMID: 26330656</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bowling H., Bhattacharya A., Klann E., Chao M.V. Deconstructing brain-derived neurotrophic factor actions in adult brain circuits to bridge an existing informational gap in neuro-cell biology. Neural. Regen. Res. 2016; 11 (3): 363–367. DOI: 10.4103/1673-5374.179031. PMID: 27127458</mixed-citation><mixed-citation xml:lang="en">Bowling H., Bhattacharya A., Klann E., Chao M.V. Deconstructing brain-derived neurotrophic factor actions in adult brain circuits to bridge an existing informational gap in neuro-cell biology. Neural. Regen. Res. 2016; 11 (3): 363–367. DOI: 10.4103/1673-5374.179031. PMID: 27127458</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Garraway S.M., Huie J.R. Spinal plasticity and behavior: BDNF-induced neuromodulation in uninjured and injured spinal cord. Neural. Plast. 2016; 2016: 9857201. DOI: 10.1155/2016/9857201. PMID: 27721996</mixed-citation><mixed-citation xml:lang="en">Garraway S.M., Huie J.R. Spinal plasticity and behavior: BDNF- induced neuromodulation in uninjured and injured spinal cord. Neural. Plast. 2016; 2016: 9857201. DOI: 10.1155/2016/9857201. PMID: 27721996</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berretta A., Tzeng Y.C., Clarkson A.N. Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor. Expert Rev. Neurother. 2014; 14 (11): 1335-1344. DOI: 10.1586/14737175.2014.969242. PMID: 25319267</mixed-citation><mixed-citation xml:lang="en">Berretta A., Tzeng Y.C., Clarkson A.N. Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor. Expert Rev. Neurother. 2014; 14 (11): 1335-1344. DOI: 10.1586/14737175.2014.969242. PMID: 25319267</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Blondeau N., Lipsky R.H., Bourourou M., Duncan M.W., Gorelick P.B., Marini A.M. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed. Res. Int. 2015; 2015: 519830. DOI: 10.1155/2015/519830. PMID: 25789320</mixed-citation><mixed-citation xml:lang="en">Blondeau N., Lipsky R.H., Bourourou M., Duncan M.W., Gorelick P.B., Marini A.M. Alpha-linolenic acid: an omega-3 fatty acid with neuro- protective properties-ready for use in the stroke clinic? Biomed. Res. Int. 2015; 2015: 519830. DOI: 10.1155/2015/519830. PMID: 25789320</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Budni J., Bellettini-Santos T., Mina F., Garcez M.L., Zugno A.I. The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging Dis. 2015; 6 (5): 331-341. DOI: 10.14336/AD.2015.0825. PMID: 26425388</mixed-citation><mixed-citation xml:lang="en">Budni J., BellettiniSantos T., Mina F., Garcez M.L., Zugno A.I. The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s dis- ease. Aging Dis. 2015; 6 (5): 331-341. DOI: 10.14336/AD.2015.0825. PMID: 26425388</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Khalin I., Alyautdin R., Kocherga G., Bakar M.A. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int. J. Nanomedicine. 2015; 10: 3245-3267. DOI: 10.2147/IJN.S77480. PMID: 25995632</mixed-citation><mixed-citation xml:lang="en">Khalin I., Alyautdin R., Kocherga G., Bakar M.A. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int. J. Nanomedicine. 2015; 10: 3245-3267. DOI: 10.2147/IJN.S77480. PMID: 25995632</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dincheva I., Lynch N.B., Lee F.S. The role of BDNF in the development of fear learning. Depress. Anxiety. 2016; 33 (10): 907-916. DOI: 10.1002/da.22497. PMID: 27699937</mixed-citation><mixed-citation xml:lang="en">Dincheva I., Lynch N.B., Lee F.S. The role of BDNF in the development of fear learning. Depress. Anxiety. 2016; 33 (10): 907-916. DOI: 10.1002/da.22497. PMID: 27699937</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C., Chan C.B., Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl. Neurodegener. 2016; 5: 2. DOI: 10.1186/s40035-015-0048-7. PMID: 26740873</mixed-citation><mixed-citation xml:lang="en">Liu C., Chan C.B., Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disor- ders. Transl. Neurodegener. 2016; 5: 2. DOI: 10.1186/s40035-015-0048- 7. PMID: 26740873</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Blaha G.R., Raghupathi R., Saatman K.E., McIntosh T.K. Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits. Neuroscience. 2000; 99 (3): 483-493. DOI: 10.1016/S0306-4522(00)00214-1. PMID: 11029540</mixed-citation><mixed-citation xml:lang="en">Blaha G.R., Raghupathi R., Saatman K.E., McIntosh T.K. Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits. Neuroscience. 2000; 99 (3): 483-493. DOI: 10.1016/S0306- 4522(00)00214-1. PMID: 11029540</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005; 1037 (1-2): 204-208. DOI: 10.1016/j.brainres.2005.01.007. PMID: 15777771</mixed-citation><mixed-citation xml:lang="en">Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005; 1037 (1-2): 204-208. DOI: 10.1016/j.brainres.2005.01.007. PMID: 15777771</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat. Med. 2009; 15 (3): 331-337. DOI: 10.1038/nm.1912. PMID: 19198615</mixed-citation><mixed-citation xml:lang="en">Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat. Med. 2009; 15 (3): 331-337. DOI: 10.1038/nm.1912. PMID: 19198615</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., Dhib-Jalbut S., Trisler D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009; 210 (1-2): 40-51. DOI: 10.1016/j.jneuroim.2009.02.017. PMID: 19361871</mixed-citation><mixed-citation xml:lang="en">Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., DhibJalbut S., Trisler D. Brain-derived neu- rotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009; 210 (1-2): 40-51. DOI: 10.1016/j.jneuroim.2009.02.017. PMID: 19361871</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J.L., Lin Y.T., Chuang P.C., Bohr V.A., Mattson M.P. BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease. Neuromolecular Med. 2014; 16 (1): 161-174. DOI: 10.1007/s12017-013-8270-x. PMID: 24114393</mixed-citation><mixed-citation xml:lang="en">Yang J.L., Lin Y.T., Chuang P.C., Bohr V.A., Mattson M.P. BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease. Neuromolecular Med. 2014; 16 (1): 161-174. DOI: 10.1007/s12017-013-8270-x. PMID: 24114393</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Otis J.M., Fitzgerald M.K., Mueller D. Infralimbic BDNF/TrkB enhancement of GluN2B currents facilitates extinction of a cocaine-conditioned place preference. J. Neurosci. 2014; 34 (17): 6057-6064. DOI: 10.1523/JNEUROSCI.4980-13.2014. PMID: 24760865</mixed-citation><mixed-citation xml:lang="en">Otis J.M., Fitzgerald M.K., Mueller D. Infralimbic BDNF/TrkB enhancement of GluN2B currents facilitates extinction of a cocaine- conditioned place preference. J. Neurosci. 2014; 34 (17): 6057-6064. DOI: 10.1523/JNEUROSCI.4980-13.2014. PMID: 24760865</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Koeva Y.A., Sivkov S.T., Akabaliev V.H., Ivanova R.Y., Deneva T.I., Grozlekova L.S., Georgieva V. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients. Folia. Med. (Plovdiv). 2014; 56 (1): 20-23. DOI: 10.2478/folmed-2014-0003. PMID: 24812918</mixed-citation><mixed-citation xml:lang="en">Koeva Y.A., Sivkov S.T., Akabaliev V.H., Ivanova R.Y., Deneva T.I., Grozlekova L.S., Georgieva V. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients. Folia. Med. (Plovdiv). 2014; 56 (1): 20-23. DOI: 10.2478/folmed-2014-0003. PMID: 24812918</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Dong E., Dzitoyeva S.G., Matrisciano F., Tueting P., Grayson D.R., Guidotti A. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice. Biol. Psychiatry. 2015; 77 (6): 589-596. DOI: 10.1016/j.biopsych.2014.08.012. PMID: 25444166</mixed-citation><mixed-citation xml:lang="en">Dong E., Dzitoyeva S.G., Matrisciano F., Tueting P., Grayson D.R., Guidotti A. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice. Biol. Psychiatry. 2015; 77 (6): 589-596. DOI: 10.1016/j.biopsych.2014.08.012. PMID: 25444166</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Deng P., Torrest A., Pollock K., Dahlenburg H., Annett G., Nolta J.A., Fink K.D. Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells. Neural. Regen. Res. 2016; 115): 702-705. DOI: 10.4103/1673-5374.182682. PMID: 27335539</mixed-citation><mixed-citation xml:lang="en">Deng P., Torrest A., Pollock K., Dahlenburg H., Annett G., Nolta J.A., Fink K.D. Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells. Neural. Regen. Res. 2016; 115): 702-705. DOI: 10.4103/1673-5374.182682. PMID: 27335539</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schäbitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulatesBax and Bcl-2 expression after tempo-rary focal cerebral ischemia. Stroke. 2000; 31 (9): 2212-2217. DOI: 10.1161/01.STR.31.9.2212. PMID: 10978054</mixed-citation><mixed-citation xml:lang="en">Schäbitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulatesBax and Bcl-2 expression after tempo- rary focal cerebral ischemia. Stroke. 2000; 31 (9): 2212-2217. DOI: 10.1161/01.STR.31.9.2212. PMID: 10978054</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schäbitz W.R., Steigleder T., Cooper-Kuhn C.M., Schwab S., Sommer C., Schneider A., Kuhn H.G. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007; 38 (7): 2165-2172. DOI: 10.1161/STROKEAHA.106.477331. PMID: 17510456</mixed-citation><mixed-citation xml:lang="en">Schäbitz W.R., Steigleder T., Cooper-Kuhn C.M., Schwab S., Sommer C., Schneider A., Kuhn H.G. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogene- sis. Stroke. 2007; 38 (7): 2165-2172. DOI: 10.1161/STROKEA- HA.106.477331. PMID: 17510456</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrer I., Krupinski J., Goutan E., Martí E., Ambrosio S., Arenas E. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 2001; 101 (3): 229-238. PMID: 11307622</mixed-citation><mixed-citation xml:lang="en">Ferrer I., Krupinski J., Goutan E., Martí E., Ambrosio S., Arenas E. Brain- derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 2001; 101 (3): 229-238. PMID: 11307622</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004; 9 (2): 189-197. DOI: 10.1016/j.ymthe.2003.10.012. PMID: 14759803</mixed-citation><mixed-citation xml:lang="en">Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004; 9 (2): 189-197. DOI: 10.1016/j.ymthe.2003.10.012. PMID: 14759803</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Qiu B., Wang J., Yao Y., Wang C., Liu J. Effects of BDNF-transfected BMSCs on neural functional recovery and synaptophysin expression in rats with cerebral infarction. Mol. Neurobiol. 2017; 54 (5): 3813-3824. DOI: 0.1007/s12035-016-9946-7. PMID: 27282770</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Qiu B., Wang J., Yao Y., Wang C., Liu J. Effects of BDNF-trans- fected BMSCs on neural functional recovery and synaptophysin expression in rats with cerebral infarction. Mol. Neurobiol. 2017; 54 (5): 3813-3824. DOI: 0.1007/s12035-016-9946-7. PMID: 27282770</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">MacLellan C.L., Keough M.B., Granter-Button S., Chernenko G.A., Butt S., Corbett D. Acritical threshold of rehabilitation involving brain-derived neurotrophic factor is required for poststroke recovery. Neurorehabil. Neural. Repair. 2011; 25 (8): 740-748. DOI: 10.1177/1545968311407517. PMID: 21705652</mixed-citation><mixed-citation xml:lang="en">MacLellan C.L., Keough M.B., GranterButton S., Chernenko G.A., Butt S., Corbett D. Acritical threshold of rehabilitation involving brain- derived neurotrophic factor is required for poststroke recovery. Neurorehabil. Neural. Repair. 2011; 25 (8): 740-748. DOI: 10.1177/1545968311407517. PMID: 21705652</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Y., Wei N., Lu T., Zhu J., Xu G., Liu X. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience. 2011; 172: 398-405. DOI: 10.1016/j.neuroscience.2010.10.054. PMID: 21034794</mixed-citation><mixed-citation xml:lang="en">Jiang Y., Wei N., Lu T., Zhu J., Xu G., Liu X. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience. 2011; 172: 398-405. DOI: 10.1016/j.neuroscience.2010.10.054. PMID: 21034794</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">van Velthoven C.T., Sheldon R.A., Kavelaars A., Derugin N., Vexler Z.S., Willemen H.L., Maas M., Heijnen C.J., Ferriero D.M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke. 2013; 44 (5): 1426-1432. DOI: 10.1161/STROKEAHA.111.000326. PMID: 23539530</mixed-citation><mixed-citation xml:lang="en">van Velthoven C.T., Sheldon R.A., Kavelaars A., Derugin N., Vexler Z.S., Willemen H.L., Maas M., Heijnen C.J., Ferriero D.M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke. 2013; 44 (5): 1426-1432. DOI: 10.1161/STROKEA- HA.111.000326. PMID: 23539530</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake K., Yamamoto W., Tadokoro M., Takagi N., Sasakawa K., Nitta A., Furukawa S., Takeo S. Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res. 2002; 935 (1-2): 24-31. DOI: 10.1016/S0006-8993(02)02420-4. PMID: 12062469</mixed-citation><mixed-citation xml:lang="en">Miyake K., Yamamoto W., Tadokoro M., Takagi N., Sasakawa K., Nitta A., Furukawa S., Takeo S. Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res. 2002; 935 (1-2): 24-31. DOI: 10.1016/S0006-8993(02)02420-4. PMID: 12062469 3</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Uchida H., Yokoyama H., Kimoto H., Kato H., Araki T. Long-term changes in the ipsilateral substantia nigra after transient focal cerebral ischaemia in rats. Int. J. Exp. Pathol. 2010; 91 (3): 256-266. DOI: 10.1111/j.1365-2613.2010.00712.x. PMID: 20353427</mixed-citation><mixed-citation xml:lang="en">chida H., Yokoyama H., Kimoto H., Kato H., Araki T. Long-term changes in the ipsilateral substantia nigra after transient focal cerebral ischaemia in rats. Int. J. Exp. Pathol. 2010; 91 (3): 256-266. DOI: 10.1111/j.1365-2613.2010.00712.x. PMID: 20353427</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ставчанский В.В., Творогова Т.В., Боцина А.Ю., Скворцова В.И., Лимборская С.А., Мясоедов Н.Ф., Дергунова Л.В. Cемакс и его С-концевой фрагмент PGP влияют на экспрессию генов нейротрофинов и их рецепторов в условиях неполной глобальной ишемии мозга крыс. Молекулярная биология. 2011; 45 (6): 1026-1035. PMID: 22295573</mixed-citation><mixed-citation xml:lang="en">Stavchanski V.V., Tvorogova T.V., Botsina A.Iu., Skvortsova V.I., Limborskaia S.A., Miasoedov N.F., Dergunova L.V. The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia. Mol. Biol. (Mosk). 2011; 45 (6): 1026-1035. PMID: 22295573. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Shu X., Zhang Y., Xu H., Kang K., Cai D. Brain-derived neurotrophic factor inhibits glucose intolerance after cerebral ischemia. Neural. Regen. Res. 2013; 8 (25): 2370-2378. DOI: 10.3969/j.issn.1673-5374.2013.25.008. PMID: 25206547</mixed-citation><mixed-citation xml:lang="en">Shu X., Zhang Y., Xu H., Kang K., Cai D. Brain-derived neurotrophic factor inhibits glucose intolerance after cerebral ischemia. Neural. Regen. Res. 2013; 8 (25): 2370-2378. DOI: 10.3969/j.issn.1673- 5374.2013.25.008. PMID: 25206547</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Корпачев В.Г., Лысенков С.П., Тель Л.З. Моделирование клинической смерти и постреанимационной болезни у крыс. Патол. физиология и эксперим. терапия. 1982; 3: 78-80. PMID: 7122145</mixed-citation><mixed-citation xml:lang="en">Korpachev V.G., Lysenkov S.P., Tel L.Z. Modeling clinical death and postresuscitation disease in rats. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 1982; 3: 78-80. PMID: 7122145. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Саморукова В.В., Мороз В.В., Волков А.В., Назаренко И.В., Горенкова Н.А. Развитие постреанимационных морфологических изменений нейронов гиппокампа и мозжечка: общие закономерности и особенности. Патол. физиология и эксперим. терапия. 2003; 2: 27-30. PMID: 12838772</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Samorukova V.V., Moroz V.V., Volkov A.V., Nazarenko I.V., Gorenkova N.A. Development of postresuscitation mor- phological changes of hippocampal and cerebellar neurons: common reg- ularities and specific features. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 2003; 2: 27-30. PMID: 12838772. [In Russ.] 4</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lee T.H., Yang J.T., Ko Y.S., Kato H., Itoyama Y., Kogure K. Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia. Brain Res. 2008; 1187: 1-11. DOI: 10.1016/j.brainres.2007.09.078. PMID: 18036511</mixed-citation><mixed-citation xml:lang="en">ee T.H., Yang J.T., Ko Y.S., Kato H., Itoyama Y., Kogure K. Influence of ischemic preconditioning on levels of nerve growth factor, brain- derived neurotrophic factor and their high-affinity receptors in hip- pocampus following forebrain ischemia. Brain Res. 2008; 1187: 1-11. DOI: 10.1016/j.brainres.2007.09.078. PMID: 18036511</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mokhtari T., Akbari M., Malek F., Kashani I.R., Rastegar T., Noorbakhsh F., GhaziKhansari M., Attari F., Hassanzadeh G. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru. 2017; 25 (1): 4. DOI: 10.1186/s40199-017-0169-x. PMID: 28202057</mixed-citation><mixed-citation xml:lang="en">Mokhtari T., Akbari M., Malek F., Kashani I.R., Rastegar T., Noorbakhsh F., GhaziKhansari M., Attari F., Hassanzadeh G. Improvement of mem- ory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru. 2017; 25 (1): 4. DOI: 10.1186/s40199-017-0169-x. PMID: 28202057</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Impellizzeri D., Campolo M., Bruschetta G., Crupi R., Cordaro M., Paterniti I., Cuzzocrea S., Esposito E. Traumatic brain injury leads to development of Parkinson’s disease related pathology in mice. Front. Neurosci. 2016; 10: 458. DOI: 10.3389/fnins.2016.00458. PMID: 27790086</mixed-citation><mixed-citation xml:lang="en">Impellizzeri D., Campolo M., Bruschetta G., Crupi R., Cordaro M., Paterniti I., Cuzzocrea S., Esposito E. Traumatic brain injury leads to development of Parkinson’s disease related pathology in mice. Front. Neurosci. 2016; 10: 458. DOI: 10.3389/fnins.2016.00458. PMID: 27790086</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Chen A.I., Xiong L.J., Tong Y.U., Mao M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed. Rep. 2013; 1 (2): 167-176. DOI: 10.3892/br.2012.48. PMID: 24648914</mixed-citation><mixed-citation xml:lang="en">Chen A.I., Xiong L.J., Tong Y.U., Mao M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed. Rep. 2013; 1 (2): 167- 176. DOI: 10.3892/br.2012.48. PMID: 24648914</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Ploughman M., Windle V., MacLellan C.L., White N., Doré J.J., Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009; 40 (4): 1490-1495. DOI: 10.1161/STROKEAHA.108.531806. PMID: 19164786</mixed-citation><mixed-citation xml:lang="en">Ploughman M., Windle V., MacLellan C.L., White N., Doré J.J., Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009; 40 (4): 1490-1495. DOI: 10.1161/STROKEAHA.108.531806. PMID: 19164786</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Kiprianova I., Freiman T.M., Desiderato S., Schwab S., Galmbacher R., Gillardon F., Spranger M. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. J. Neurosci. Res. 1999; 56 (1): 21-27. DOI: 10.1002/(SICI)1097-4547(19990401)56:1&lt;21::AID-JNR3&gt;3.0.CO;2-Q. PMID: 10213471</mixed-citation><mixed-citation xml:lang="en">Kiprianova I., Freiman T.M., Desiderato S., Schwab S., Galmbacher R., Gillardon F., Spranger M. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. J. Neurosci. Res. 1999; 56 (1): 21-27. DOI: 10.1002/(SICI)1097- 4547(19990401)56:1&lt;21::AID-JNR3&gt;3.0.CO;2-Q. PMID: 10213471</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Pardridge W.M. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 2006; 1111 (1): 227-229. DOI: PMID: 16884698</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Pardridge W.M. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 2006; 1111 (1): 227-229. DOI: PMID: 16884698</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">D’Cruz B.J., Fertig K.C., Filiano A.J., Hicks S.D., DeFranco D.B., Callaway C.W. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J. Cereb. Blood Flow Metab. 2002; 22 (7): 843-851. DOI: 10.1097/00004647-200207000-00009. PMID: 12142569</mixed-citation><mixed-citation xml:lang="en">D’Cruz B.J., Fertig K.C., Filiano A.J., Hicks S.D., DeFranco D.B., Callaway C.W. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J. Cereb. Blood Flow Metab. 2002; 22 (7): 843-851. DOI: 10.1097/00004647-200207000- 00009. PMID: 12142569</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Ostrowski R.P., Graupner G., Titova E., Zhang J., Chiu J., Dach N., Corleone D., Tang J., Zhang J.H. The hyperbaric oxygen preconditioning-induced brain is mediated by a reduction of early apoptosis after transient cerebral ischemia Neurobiol. Dis. 2008; 29 (1): 1–13. DOI: 10.1016/j.nbd.2007.07.020. PMID: 17822911</mixed-citation><mixed-citation xml:lang="en">Ostrowski R.P., Graupner G., Titova E., Zhang J., Chiu J., Dach N., Corleone D., Tang J., Zhang J.H. The hyperbaric oxygen precondition- ing-induced brain is mediated by a reduction of early apoptosis after transient cerebral ischemia Neurobiol. Dis. 2008; 29 (1): 1–13. DOI: 10.1016/j.nbd.2007.07.020. PMID: 17822911</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuroprotective against ischemic brain injury through its effects on the PI3K/Akt signaling pathway. Neuroscience. 2012; 210: 442–450. DOI: 10.1016/j.neuroscience.2012.03.008. PMID: 22450229</mixed-citation><mixed-citation xml:lang="en">shrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuro- protective against ischemic brain injury through its effects on the PI3K/Akt signaling pathway. Neuroscience. 2012; 210: 442–450. DOI: 10.1016/j.neuroscience.2012.03.008. PMID: 22450229</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Singh M., Su C. Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy. Brain Res. 2013; 1514: 98-106. DOI: 10.1016/j.brainres.2013.01.027. PMID: 23340161</mixed-citation><mixed-citation xml:lang="en">Singh M., Su C. Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy. Brain Res. 2013; 1514: 98-106. DOI: 10.1016/j.brainres.2013.01.027. PMID: 23340161</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Ding X., Zhang R., Jiang W., Sun X., Xia Z., Wang X., Wu E., Zhang Y., Hu Y. Harpagoside ameliorates the amyloid-в-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways. Neuroscience. 2015; 303: 103-114. DOI: 10.1016/j.neuroscience.2015.06.042. PMID: 26135675</mixed-citation><mixed-citation xml:lang="en">Li J., Ding X., Zhang R., Jiang W., Sun X., Xia Z., Wang X., Wu E., Zhang Y., Hu Y. Harpagoside ameliorates the amyloid-в-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways. Neuroscience. 2015; 303: 103-114. DOI: 10.1016/j.neuroscience.2015.06.042. PMID: 26135675</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Liang C., Tan S., Huang Q., Lin J., Lu Z., Lin X. Pratensein ameliorates в-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels. Neurosci. Lett. 2015; 592: 48-53. DOI: 0.1016/j.neulet.2015.03.003. PMID: 25748315</mixed-citation><mixed-citation xml:lang="en">Liang C., Tan S., Huang Q., Lin J., Lu Z., Lin X. Pratensein ameliorates в-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels. Neurosci. Lett. 2015; 592: 48-53. DOI: 0.1016/j.neulet.2015.03.003. PMID: 25748315</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Fahimi A., Baktir M.A., Moghadam S., Mojabi F.S., Sumanth K., McNerney M.W., Ponnusamy R., Salehi A. Physical exercise induces structural alterations in the hippocampal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Struct. Funct. 2017; 222 (4): 1797-1808. DOI: 10.1007/s00429-016-1308-8. PMID: 27686571</mixed-citation><mixed-citation xml:lang="en">Fahimi A., Baktir M.A., Moghadam S., Mojabi F.S., Sumanth K., McNerney M.W., Ponnusamy R., Salehi A. Physical exercise induces structural alterations in the hippocampal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Struct. Funct. 2017; 222 (4): 1797- 1808. DOI: 10.1007/s00429-016-1308-8. PMID: 27686571</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Kim G., Kim E. The effects of antecedent exercise on motor function recovery and brain-derived neurotrophic factor expression after focal cerebral ischemia in rats. J. Phys. Ther. Sci. 2013; 25 (5): 553–556. DOI: 10.1589/jpts.25.553. PMID: 24259800</mixed-citation><mixed-citation xml:lang="en">Kim G., Kim E. The effects of antecedent exercise on motor function recovery and brain-derived neurotrophic factor expression after focal cerebral ischemia in rats. J. Phys. Ther. Sci. 2013; 25 (5): 553–556. DOI: 10.1589/jpts.25.553. PMID: 24259800</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Shih P.C., Yang Y.R., Wang R.Y. Effects of exercise intensity on spatial memory performance and hippocampal synaptic plasticity in transient brain ischemic rats. PLoS One. 2013; 8 (10): e78163. DOI: 10.1371/journal.pone.0078163. PMID: 24205142</mixed-citation><mixed-citation xml:lang="en">Shih P.C., Yang Y.R., Wang R.Y. Effects of exercise intensity on spatial memory performance and hippocampal synaptic plasticity in transient brain ischemic rats. PLoS One. 2013; 8 (10): e78163. DOI: 10.1371/journal.pone.0078163. PMID: 24205142</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Leeds P., Leng Y., Chalecka-Franaszek E., Chuang D.M. Neurotrophinsprotect against cytosine arabinoside-induced apoptosis of immature rat cerebellar neurons. Neurochem. Int. 2005; 46 (1): 61–72. DOI: 10.1016/j.neuint.2004.07.001. PMID: 15567516</mixed-citation><mixed-citation xml:lang="en">Seeds P., Leng Y., ChaleckaFranaszek E., Chuang D.M. Neurotrophinsprotect against cytosine arabinoside-induced apoptosis of immature rat cerebellar neurons. Neurochem. Int. 2005; 46 (1): 61–72. DOI: 10.1016/j.neuint.2004.07.001. PMID: 15567516</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Géral C., Angelova А., Lesieur S. From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics. 2013; 5 (1): 127-167. DOI: 10.3390/pharmaceutics5010127. PMID: 24300402</mixed-citation><mixed-citation xml:lang="en">Géral C., Angelova A., Lesieur S. From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics. 2013; 5 (1): 127-167. DOI: 10.3390/pharmaceutics5010127. PMID: 24300402</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Huang L., Applegate P.M., Gatling J.W., Mangus D.B., Zhang J., Applegate R.L.2nd. A systematic review of neuroprotective strategies after cardiac arrest: from bench to bedside (part II-comprehensive protection). Med. Gas. Res. 2014; 4: 10. DOI: 10.1186/2045-9912-4-10. PMID: 25671079</mixed-citation><mixed-citation xml:lang="en">Huang L., Applegate P.M., Gatling J.W., Mangus D.B., Zhang J., Applegate R.L.2nd. A systematic review of neuroprotective strategies after cardiac arrest: from bench to bedside (part II-comprehensive pro- tection). Med. Gas. Res. 2014; 4: 10. DOI: 10.1186/2045-9912-4-10. PMID: 25671079</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Kim D.H., Zhao X., Tu C.H., Casaccia-Bonnefil P., Chao M.V. Prevention of apoptotic but not necrotic cell death following neuronal injury by neurotrophins signaling through the tyrosine kinase receptor. J. Neurosurg. 2004; 100 (1): 79-87. DOI: 10.3171/jns.2004.100.1.0079. PMID: 14743916</mixed-citation><mixed-citation xml:lang="en">Kim D.H., Zhao X., Tu C.H., CasacciaBonnefil P., Chao M.V. Prevention of apoptotic but not necrotic cell death following neuronal injury by neurotrophins signaling through the tyrosine kinase recep- tor. J. Neurosurg. 2004; 100 (1): 79-87. DOI: 10.3171/jns.2004. 100.1.0079. PMID: 14743916</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Ma D., Feng G., Ma Y., Hu H. Recombinant AAV-mediated expression of human BDNF protects neurons against cell apoptosis in Abeta-induced neuronal damage model. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2007; 27 (3): 233-236. DOI: 10.1007/s11596-007-</mixed-citation><mixed-citation xml:lang="en">Liu Z., Ma D., Feng G., Ma Y., Hu H. Recombinant AAV-mediated expression of human BDNF protects neurons against cell apoptosis in Abeta-induced neuronal damage model. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2007; 27 (3): 233-236. DOI: 10.1007/s11596-007- 0304-x. PMID: 17641830</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">-x. PMID: 17641830</mixed-citation><mixed-citation xml:lang="en">Takeshima Y., Nakamura M., Miyake H., Tamaki R., Inui T., Horiuchi K., Wajima D., Nakase H. Neuroprotection with intraventricular brain- derived neurotrophic factor in rat venous occlusion model. Neurosurgery. 2011; 68 (5): 1334-1341. DOI: 10.1227/NEU.0b013e 31820c048e. PMID: 21307800</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Takeshima Y., Nakamura M., Miyake H., Tamaki R., Inui T., Horiuchi K., Wajima D., Nakase H. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Neurosurgery. 2011; 68 (5): 1334-1341. DOI: 10.1227/NEU.0b013e31820c048e. PMID: 21307800</mixed-citation><mixed-citation xml:lang="en">Kazim S.F., Iqbal K. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease. Mol. Neurodegener. 2016; 11 (1): 50. DOI: 10.1186/s13024-016-0119-y. PMID: 27400746</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Kazim S.F., Iqbal K. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease. Mol. Neurodegener. 2016; 11 (1): 50. DOI: 10.1186/s13024-016-0119-y. PMID: 27400746</mixed-citation><mixed-citation xml:lang="en">Khalin I., Alyautdin R., Kocherga G., Bakar M.A. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int. J. Nanomedicine. 2015; 10: 3245-3267. DOI: 10.2147/IJN. S77480. PMID: 25995632</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Khalin I., Alyautdin R., Kocherga G., Bakar M.A. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int. J. Nanomedicine. 2015; 10: 3245-3267. DOI: 10.2147/IJN.S77480. PMID: 25995632</mixed-citation><mixed-citation xml:lang="en">Pardridge W.M. Drug transport across the blood-brain barrier J. Cereb. Blood Flow Metab. 2012; 32 (11): 1959-1972. DOI: 10.1038/jcbfm.2012.126. PMID: 22929442</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Pardridge W.M. Drug transport across the blood-brain barrier J. Cereb. Blood Flow Metab. 2012; 32 (11): 1959-1972. DOI: 10.1038/jcbfm.2012.126. PMID: 22929442</mixed-citation><mixed-citation xml:lang="en">Alyautdin R., Khalin I., Nafeeza M.I., Haron M.H., Kuznetsov D. Nanoscale drug delivery systems and the blood-brain barrier. Int. J. Nanomedicine. 2014; 9: 795-811. DOI: 10.2147/IJN.S52236. PMID: 24550672</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Alyautdin R., Khalin I., Nafeeza M.I., Haron M.H., Kuznetsov D. Nanoscale drug delivery systems and the blood-brain barrier. Int. J. Nanomedicine. 2014; 9: 795-811. DOI: 10.2147/IJN.S52236. PMID: 24550672</mixed-citation><mixed-citation xml:lang="en">Shi Q., Zhang P., Zhang J., Chen X., Lu H., Tian Y., Parker T.L., Liu Y. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett. 2009; 465 (3): 220-225. DOI: 10.1016/j.neulet.2009.08.049. PMID: 19703519</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Q., Zhang P., Zhang J., Chen X., Lu H., Tian Y., Parker T.L., Liu Y. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett. 2009; 465 (3): 220-225. DOI: 10.1016/j.neulet.2009.08.049. PMID: 19703519</mixed-citation><mixed-citation xml:lang="en">Liu X., Zhu Z., Kalyani M., Janik J.M., Shi H. Effects of energy status and diet on Bdnf expression in the ventromedial hypothalamus of male and female rats. Physiol. Behav. 2014; 130: 99-107. DOI: 10.1016/j.phys- beh.2014.03.028. PMID: 24709620</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Zhu Z., Kalyani M., Janik J.M., Shi H. Effects of energy status and diet on Bdnf expression in the ventromedial hypothalamus of male and female rats. Physiol. Behav. 2014; 130: 99-107. DOI: 10.1016/j.phys-beh.2014.03.028. PMID: 24709620</mixed-citation><mixed-citation xml:lang="en">Gudasheva T.A., Povarnina P.Y., Seredenin S.B. Dipeptide mimetic of the brain-derived neurotrophic factor prevents impairments of neurogene- sis in stressed mice. Byulleten Experimentalnoi Biologii i Meditsiny. 2017; 162 (4): 454-457. DOI: 10.1007/s10517-017-3638-9. PMID: 28243910</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Поварнина П.Ю., Середенин С.Б. Дипептидный миметик мозгового нейротрофического фактора предотвращает нарушение нейрогенеза у стрессированных мышей. Бюл. эксперим. биологии и медицины. 2016; 162 (10): 448-451.</mixed-citation><mixed-citation xml:lang="en">Gudasheva T.A., Povarnina P.Y., Logvinov I.O., Antipova T.A., Seredenin S.B. Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats. Drug Des. Devel. Ther. 2016; 10: 3545-3553. DOI: 10.2147/DDDT.S118768. PMID: 27843294</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Gudasheva T.A., Povarnina P.Y., Logvinov I.O., Antipova T.A., Seredenin S.B. Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats. Drug Des. Devel. Ther. 2016; 10: 3545-3553. DOI: 10.2147/DDDT.S118768. PMID: 27843294</mixed-citation><mixed-citation xml:lang="en">Chen X., Wang K. The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015. Acta Pharm. Sin. B. 2016; 6 (6): 522-530. DOI: 10.1016/j.apsb.2016.06.013. PMID: 27818918</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Wang K. The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015. Acta Pharm. Sin. B. 2016; 6 (6): 522-530. DOI: 10.1016/j.apsb.2016.06.013. PMID: 27818918</mixed-citation><mixed-citation xml:lang="en">Zhao H., Alam A., San C.Y., Eguchi S., Chen Q., Lian Q., Ma D. Molecular mechanisms of brain-derived neurotrophic factor in neuro- protection: recent developments. Brain Res. 2017; 1665: 1-21. DOI: 10.1016/j.brainres.2017.03.029. PMID: 28396009</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao H., Alam A., San C.Y., Eguchi S., Chen Q., Lian Q., Ma D. Molecular mechanisms of brain-derived neurotrophic factor in neuroprotection: recent developments. Brain Res. 2017; 1665: 1-21. DOI: 10.1016/j.brainres.2017.03.029. PMID: 28396009</mixed-citation><mixed-citation xml:lang="en">Wang J., Zhang S., Ma H., Yang S., Liu Z., Wu X., Wang S., Zhang Y., Liu Y. Chronic intermittent hypobaric hypoxia pretreatment ameliorates ischemia-induced cognitive dysfunction through activation of ERK1/2-CREB-BDNF pathway in anesthetized mice. Neurochem. Res. 2017; 42 (2): 501-512. DOI: 10.1007/s11064-016-2097-4. PMID: 27822668</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Zhang S., Ma H., Yang S., Liu Z., Wu X., Wang S., Zhang Y., Liu Y. Chronic intermittent hypobaric hypoxia pretreatment ameliorates ischemia-induced cognitive dysfunction through activation of ERK1/2-CREB-BDNF pathway in anesthetized mice. Neurochem. Res. 2017; 42 (2): 501-512. DOI: 10.1007/s11064-016-2097-4. PMID: 27822668</mixed-citation><mixed-citation xml:lang="en">Shin M.K., Kim H.G., Kim K.L. A novel brain-derived neurotrophic fac- tor-modulating peptide attenuates Aв1-42-induced neurotoxicity in vitro. Neurosci. Lett. 2015; 595: 63-68. DOI: 10.1016/j.neulet.2015. 03.070. PMID: 25849526</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Shin M.K., Kim H.G., Kim K.L. A novel brain-derived neurotrophic factor-modulating peptide attenuates Aв1-42-induced neurotoxicity in vitro. Neurosci. Lett. 2015; 595: 63-68. DOI: 10.1016/j.neulet.2015.03.070. PMID: 25849526</mixed-citation><mixed-citation xml:lang="en">Yang L., Jiang Y., Wen Z., Xu X., Xu X., Zhu J., Xie X., Xu L., Xie Y., Liu X., Xu G. Over-expressed EGR1 may exaggerate ischemic injury after exper- imental stroke by decreasing BDNF expression. Neuroscience. 2015; 290: 509-517. DOI: 10.1016/j.neuroscience.2015.01.020. PMID: 25637490</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L., Jiang Y., Wen Z., Xu X., Xu X., Zhu J., Xie X., Xu L., Xie Y., Liu X., Xu G. Over-expressed EGR1 may exaggerate ischemic injury after experimental stroke by decreasing BDNF expression. Neuroscience. 2015; 290: 509-517. DOI: 10.1016/j.neuroscience.2015.01.020. PMID: 25637490</mixed-citation><mixed-citation xml:lang="en">Patz S., Wahle P. Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression. Eur. J. Neurosci. 2004; 20 (3): 701-708. DOI: 10.1111/j.1460-9568.2004.03519.x. PMID: 15255980</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Patz S., Wahle P. Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression. Eur. J. Neurosci. 2004; 20 (3): 701-708. DOI: 10.1111/j.1460--9568.2004.03519.x. PMID: 15255980</mixed-citation><mixed-citation xml:lang="en">Kuo L.T., Groves M.J., Scaravilli F., Sugden D., An S.F. Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy. Neuroscience. 2007; 147 (2): 491-507. DOI: 10.1016/j.neuro- science.2007.04.023. PMID: 17532148</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo L.T., Groves M.J., Scaravilli F., Sugden D., An S.F. Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy. Neuroscience. 2007; 147 (2): 491-507. DOI: 10.1016/j.neuroscience.2007.04.023. PMID: 17532148</mixed-citation><mixed-citation xml:lang="en">Rosso P., De Nicolò S., Carito V., Fiore M., Iannitelli A., Moreno S., Tirassa P. Ocular nerve growth factor administration modulates brain- derived neurotrophic factor signaling in prefrontal cortex of healthy and diabetic rats. CNS Neurosci. Ther. 2017; 23 (3): 198-208. DOI: 10.1111/cns.12661. PMID: 28044424</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Rosso P., De Nicolò S., Carito V., Fiore M., Iannitelli A., Moreno S., Tirassa P. Ocular nerve growth factor administration modulates brain-derived neurotrophic factor signaling in prefrontal cortex of healthy and diabetic rats. CNS Neurosci. Ther. 2017; 23 (3): 198-208. DOI: 10.1111/cns.12661. PMID: 28044424</mixed-citation><mixed-citation xml:lang="en">Avrushchenko M.Sh., Ostrova I.V., Zarzhetsky Yu.V., Moroz V.V., Gudasheva T.A., Seredenin S.B. Effect of the nerve growth factor mimetic GK-2 on post-resuscitation expression of neurotrophic fac- tors. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 2015; 59 (2): 12-18. PMID: 26571801. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Аврущенко М.Ш., Острова И.В., Заржецкий Ю.В., Мороз В.В., Гудашева Т.А., Середенин С.Б. Влияние миметика фактора роста нервов ГК-2 на постреанимационную экспрессию нейротрофических факторов. Патолог. физиология и эксперим. терапия. 2015; 59 (2): 12-18. PMID: 26571801</mixed-citation><mixed-citation xml:lang="en">Аврущенко М.Ш., Острова И.В., Заржецкий Ю.В., Мороз В.В., Гудашева Т.А., Середенин С.Б. Влияние миметика фактора роста нервов ГК-2 на постреанимационную экспрессию нейротрофических факторов. Патолог. физиология и эксперим. терапия. 2015; 59 (2): 12-18. PMID: 26571801</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
